[Costs and financial feasibility of long-term drug therapy of chronic polyarthritis]

The annual costs of the most common basic therapies in Germany will be analyzed. The costs in Deutsche marks will be divided as drug charges, physician charges and laboratory expenses. There are significant price differences also in equipotent preparations.